Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
05 August 2023 | Story Lacea Loader

All academic activities on the campuses of the University of the Free State (UFS) will resume face-to-face on Monday 7 August 2023.

This decision by the university’s executive management comes after campus-wide protests on 2 August 2023, and the subsequent decision to continue the academic programme online until 4 August 2023.

The university can confirm that a large number of UFS-registered students funded by the National Student Financial Aid Scheme (NSFAS) who have been excluded from payment, have received their allowances on Friday 4 August 2023. The university is aware that a small number of students have not yet onboarded successfully with eZaga – an online digital banking service tasked with disbursing direct payments to NSFAS beneficiaries. These students have been requested to urgently onboard successfully with eZaga in order to receive their allowances.

On a sectoral level, the university would also like to confirm that a statement has been issued by Universities South Africa (USAf) in which NSFAS and the Department of Higher Education, Science and Innovation are, among others, requested to urgently resolve the matter of the direct payment of allowances to students. The UFS fully supports the statement and is hopeful that an amicable and urgent solution to the matter can be found.

Protection Services and the South African Police Service remain on high alert and are monitoring the situation on the campuses closely. The necessary security measures are in place to ensure the safety of students and staff.

Prof Francis Petersen, Vice-Chancellor and Principal, will address our staff and students on 8 August 2023 about last week’s protest action. Please monitor the communication platforms for more information on this important engagement session.

message from Prof Francis Petersen, Vice-Chancellor and Principal, to staff and students about last week’s protest was also shared on 3 August 2023.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept